In 2020, the growth of China’s API export was stimulated by the epidemic, which boosted the global demand for ANTI-epidemic APIS, and also affected the production of other major API producers such as India and the European Union. As a result, the transfer orders of China’s API from the international market increased. Specifically, the export quantity of China’s API increased by 7.5% year on year, reaching 10.88 million tons. From specific export category, anti-infection, vitamins, hormones, antipyretic analgesic, part of antibiotic resistance to disease related API category of export amount is mostly realized the different levels of growth, some specific varieties is growing rapidly, such as dexamethasone exports rose 55% year-on-year, lamivudine, vitamin C, vitamin E and other exports more than 30% year-on-year growth, Paracetamol, annannin and other exports year-on-year growth of more than 20%.
3. Characterization After purification, extensive characterization is conducted to assess the quality and potency of the APIs. This includes various analytical techniques such as High-Performance Liquid Chromatography (HPLC), mass spectrometry, and nuclear magnetic resonance spectroscopy, ensuring that every batch meets stringent specifications.
api in pharmaceutical manufacturing
The effectiveness of light stabilizers can greatly influence the lifecycle of plastic products. By enhancing the photostability of these materials, manufacturers can reduce the frequency of replacements, minimizing waste and energy consumption. Moreover, the incorporation of light stabilizers can lead to more sustainable plastic solutions, aligning with global efforts towards environmental conservation and responsible manufacturing practices.